Latest LYRA reports update at 2024-04-30: 2024-Q12023-Q42023-Q1
Lyra Therapeutics logo
Lyra Therapeutics LYRA
$ 0.39 -0.85%

Lyra Therapeutics Financial Statements 2011-2024 | LYRA

Annual Financial Statements Lyra Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

311 M 57.4 M 53.1 M 131 M - - - - - - - - -

Shares

49.8 M 30.2 M 13 M 12.4 M - - - - - - - - -

Historical Prices

6.24 1.9 4.09 10.6 - - - - - - - - -

Net Income

-62.7 M -55.3 M -43.5 M -22.1 M -16.3 M -6.03 M - - - - - - -

Revenue

1.56 M 1.36 M 285 K - - 1.24 M - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-67.1 M -56.3 M -43.6 M -22.2 M -16.5 M - - - - - - - -

Interest Expense

- - - - - - - - - - - - -

EBITDA

-66.8 M -55.2 M -42.6 M -22.1 M -16.5 M -7.18 M - - - - - - -

Operating Expenses

68.7 M 57.7 M 43.9 M 22.2 M - - - - - - - - -

General and Administrative Expenses

19.1 M 17.6 M 14.2 M 9.69 M 4.49 M 3.53 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement Lyra Therapeutics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

64 M 57.2 M 57 M 43.7 M 36.8 M 31.8 M 36.8 M 33.9 M 13 M 13 M 13 M 13 M 12.9 M 12.9 M 12.9 M 8.18 M 231 K 231 K 221 K 186 K 170 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-22.5 M - -15.7 M -15.6 M -16.3 M - -14.8 M -14.4 M -11.9 M - -11.1 M -11 M -7.8 M - -6.33 M -4.54 M -4.23 M - -4.16 M -4.2 M -3.59 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

532 K - 544 K 458 K 410 K - 359 K 525 K 468 K - 14 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-23.5 M - -16.8 M -16.5 M -17.3 M - -14.8 M -14.4 M -11.9 M - -11.1 M -11.1 M -7.83 M - -6.36 M -4.54 M -4.25 M - -4.23 M -4.28 M -3.62 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-23.4 M - - - -17 M - -14.5 M -14.1 M -11.6 M - -10.7 M -10.8 M -7.76 M - -6.33 M -4.53 M -4.24 M - -4.22 M -4.28 M -3.62 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

24.1 M - 17.4 M 17 M 17.7 M - 15.2 M 14.9 M 12.4 M - 11.1 M 11.1 M 7.83 M - 6.36 M 4.54 M 4.25 M - 4.23 M 4.28 M 3.62 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

5.82 M - 5 M 4.57 M 5.13 M - 5.14 M 4.13 M 3.89 M - 4.02 M 3.56 M 3.06 M - 2.65 M 2.44 M 1.28 M - 1.38 M 865 K 860 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency